Sawai Group Holdings Co., Ltd. (4887.T)
JPY 2033.5
(-1.09%)
JPY 2033.5
(-1.09%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 176.86 Billion JPY | -11.72% |
| 2022 | 200.34 Billion JPY | 3.37% |
| 2021 | 193.81 Billion JPY | 3.52% |
| 2020 | 187.21 Billion JPY | 2.56% |
| 2019 | 182.53 Billion JPY | -0.98% |
| 2018 | 184.34 Billion JPY | 9.68% |
| 2017 | 168.06 Billion JPY | 26.95% |
| 2016 | 132.39 Billion JPY | 7.21% |
| 2015 | 123.49 Billion JPY | 17.11% |
| 2014 | 105.45 Billion JPY | 17.4% |
| 2013 | 89.82 Billion JPY | 11.58% |
| 2012 | 80.5 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 44.32 Billion JPY | 8.63% |
| 2023 FY | 176.86 Billion JPY | -11.72% |
| 2023 Q3 | 48.66 Billion JPY | -9.55% |
| 2023 Q4 | 40.8 Billion JPY | -16.14% |
| 2023 Q1 | 52.98 Billion JPY | 7.59% |
| 2023 Q2 | 53.8 Billion JPY | 1.53% |
| 2022 Q4 | 49.25 Billion JPY | -9.92% |
| 2022 Q3 | 54.67 Billion JPY | 13.48% |
| 2022 Q2 | 48.18 Billion JPY | -0.1% |
| 2022 Q1 | 48.23 Billion JPY | 6.73% |
| 2022 FY | 200.34 Billion JPY | 3.37% |
| 2021 Q4 | 45.18 Billion JPY | -11.95% |
| 2021 Q1 | 50.48 Billion JPY | 13.4% |
| 2021 FY | 193.81 Billion JPY | 3.52% |
| 2021 Q3 | 51.32 Billion JPY | 9.63% |
| 2021 Q2 | 46.81 Billion JPY | -7.27% |
| 2020 Q3 | 52.52 Billion JPY | 13.62% |
| 2020 Q1 | 43.94 Billion JPY | 3.95% |
| 2020 FY | 187.21 Billion JPY | 2.56% |
| 2020 Q4 | 44.52 Billion JPY | -15.24% |
| 2020 Q2 | 46.23 Billion JPY | 5.21% |
| 2019 Q4 | 42.27 Billion JPY | -15.09% |
| 2019 Q3 | 49.78 Billion JPY | 14.85% |
| 2019 Q2 | 43.34 Billion JPY | -8.03% |
| 2019 FY | 182.53 Billion JPY | -0.98% |
| 2019 Q1 | 47.13 Billion JPY | 1.7% |
| 2018 Q2 | 43.49 Billion JPY | -3.98% |
| 2018 Q3 | 49.2 Billion JPY | 13.13% |
| 2018 Q1 | 45.29 Billion JPY | -12.09% |
| 2018 FY | 184.34 Billion JPY | 9.68% |
| 2018 Q4 | 46.34 Billion JPY | -5.82% |
| 2017 FY | 168.06 Billion JPY | 26.95% |
| 2017 Q1 | 33.64 Billion JPY | 8.35% |
| 2017 Q4 | 51.52 Billion JPY | 12.56% |
| 2017 Q3 | 45.78 Billion JPY | 23.36% |
| 2017 Q2 | 37.11 Billion JPY | 10.3% |
| 2016 Q2 | 32.46 Billion JPY | -1.46% |
| 2016 Q4 | 31.05 Billion JPY | -13.64% |
| 2016 Q1 | 32.94 Billion JPY | 5.89% |
| 2016 Q3 | 35.95 Billion JPY | 10.75% |
| 2016 FY | 132.39 Billion JPY | 7.21% |
| 2015 FY | 123.49 Billion JPY | 17.11% |
| 2015 Q4 | 31.11 Billion JPY | -6.89% |
| 2015 Q3 | 33.41 Billion JPY | 13.01% |
| 2015 Q2 | 29.57 Billion JPY | 0.63% |
| 2015 Q1 | 29.38 Billion JPY | 16.32% |
| 2014 Q4 | 25.26 Billion JPY | -15.75% |
| 2014 Q3 | 29.98 Billion JPY | 19.58% |
| 2014 Q2 | 25.07 Billion JPY | -0.18% |
| 2014 Q1 | 25.12 Billion JPY | 14.76% |
| 2014 FY | 105.45 Billion JPY | 17.4% |
| 2013 Q2 | 20.84 Billion JPY | -4.87% |
| 2013 Q1 | 21.9 Billion JPY | 12.38% |
| 2013 Q4 | 21.89 Billion JPY | -13.07% |
| 2013 FY | 89.82 Billion JPY | 11.58% |
| 2013 Q3 | 25.18 Billion JPY | 20.84% |
| 2012 Q4 | 19.49 Billion JPY | -13.61% |
| 2012 Q2 | 18.76 Billion JPY | 0.0% |
| 2012 FY | 80.5 Billion JPY | 0.0% |
| 2012 Q3 | 22.56 Billion JPY | 20.26% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -184.587% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 95.852% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 43.774% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | 59.35% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -2185.504% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | -19.296% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -145.492% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 76.156% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -1325.617% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | -24.809% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | -71.903% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -219.211% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -475.198% |
| Tsumura & Co. | 150.84 Billion JPY | -17.248% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | -134.009% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -223.698% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 22.406% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -332.542% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | -133.558% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | -47.962% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -3409.167% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -277.145% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -3064.065% |
| MedRx Co., Ltd | 26 Million JPY | -680138.462% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -1509.338% |
| Solasia Pharma K.K. | 617 Million JPY | -28564.83% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -181.435% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -289306.336% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 88.023% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -699.046% |